Korean Post-marketing Surveillance for Reyataz®

NCT01450605 · clinicaltrials.gov ↗

COMPLETED

Status

601

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV-1

Interventions

DRUG: No Intervention

Sponsor

Bristol-Myers Squibb